Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fuji
Novartis
Farmers Insurance
Harvard Business School
US Department of Justice
Cantor Fitzgerald
Dow
Covington
Colorcon

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202374

« Back to Dashboard

NDA 202374 describes TRIAMCINOLONE ACETONIDE, which is a drug marketed by Actavis Mid Atlantic, Alpharma Us Pharms, Ambix, Fougera Pharms, G And W Labs, Glenmark Pharms Ltd, Lupin Atlantis, Morton Grove, Mylan Pharms Inc, Perrigo New York, Pharmaderm, Pharmafair, Taro, Teligent Pharma Inc, Topiderm, Vintage, Parnell, Sandoz Inc, Watson Labs, Akorn, G And W Labs Inc, Wockhardt, Wockhardt Eu Operatn, Glenmark Pharms, Lyne, Perrigo Israel, Perrigo Uk Finco, Riconpharma Llc, and Cmp Pharma Inc, and is included in seventy-seven NDAs. It is available from sixty-two suppliers. Additional details are available on the TRIAMCINOLONE ACETONIDE profile page.

The generic ingredient in TRIAMCINOLONE ACETONIDE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Eighty-five suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Pharmacology for NDA: 202374
Medical Subject Heading (MeSH) Categories for 202374
Suppliers and Packaging for NDA: 202374
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRIAMCINOLONE ACETONIDE triamcinolone acetonide LOTION;TOPICAL 202374 ANDA VersaPharm Incorporated 61748-219 61748-219-60 60 mL in 1 BOTTLE, WITH APPLICATOR (61748-219-60)
TRIAMCINOLONE ACETONIDE triamcinolone acetonide LOTION;TOPICAL 202374 ANDA VersaPharm Incorporated 61748-220 61748-220-60 60 mL in 1 BOTTLE, WITH APPLICATOR (61748-220-60)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:LOTION;TOPICALStrength0.025%
Approval Date:May 8, 2013TE:ATRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:LOTION;TOPICALStrength0.1%
Approval Date:May 8, 2013TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Dow
Novartis
QuintilesIMS
Colorcon
US Department of Justice
Daiichi Sankyo
Merck
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot